Recombinant factor VIIa for unlicensed indications--a definite No or a cautious Maybe in selected patients?

Int J Clin Pract. 2010 Oct;64(11):1468-1471. doi: 10.1111/j.1742-1241.2010.02413.x. Epub 2010 Aug 16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Critical Illness
  • Emergencies
  • Factor VIIa / adverse effects
  • Factor VIIa / therapeutic use*
  • Hemorrhage / prevention & control*
  • Hemostatics / therapeutic use*
  • Humans
  • Off-Label Use*
  • Patient Selection
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Risk Factors
  • Thrombosis / chemically induced

Substances

  • Hemostatics
  • Recombinant Proteins
  • recombinant FVIIa
  • Factor VIIa